Anti-CGRP Migraine Therapy

Anti-CGRP Migraine Therapy

Anti-CGRP Migraine Therapy
Anti-CGRP Migraine Therapy — Source: KBS "The Secret of Life and Death"

Source : KBS "The Secret of Life and Death"

Anti-CGRP antibody injection — what kind of treatment is it?

When a migraine attack begins, at the trigeminal nerve endings CGRPfloods out, dilating vessels and amplifying pain signals. Anti-CGRP antibodies bind to this substance and block that pathway.
If a painkiller suppresses pain that has already begun, this instead A preventive injection that makes headaches harder to start. It is the first targeted therapy developed specifically against the mechanism of migraine.

Who treatment is for and how it is given

Migraine on 4 or more days a month · Those for whom conventional preventives failed · Chronic migraine with pain on 15 or more days a month · Frequent users of analgesics
It is a subcutaneous injection you can give yourself once a month, and depending on the agent, some are given once every three months. In clinical trials, the proportion whose headache frequency and intensity fell by half or more was 60~70%.
The effect appears from one month onward.

Available in Korea Representative anti-CGRP agents

Galcanezumab과 Fremanezumabare available. Both are self-administered subcutaneous injections. We select medication by considering headache patterns and daily routines together.
Patients who do not respond to existing oral medication, or who cannot take it because of side effectsin particular.

GalcanezumabFremanezumab
Route of administrationA subcutaneous injection once a monthIt can be injected once a month or once every three months
EffectReduces both the frequency and intensity of migraine attacksMultiple clinical results show seizure days reduced by half or more with long-term administration
FeaturesIt takes effect relatively quickly after administration with few side effectsThe dosing interval can be matched to the patient's routine, making long-term use easier
IndicationsPatients who do not respond to existing oral medication, or who cannot take it because of side effectsPatients who do not respond to existing oral medication, or who cannot take it because of side effects
OthersAlso used in the treatment of cluster headacheSafety has been established to the extent that it can be given to children weighing 45 kg or more

First-line migraine prevention — advantages of the treatment

By blocking migraine before the pain begins, A breakthrough treatment that restores quality of life diminished by frequent migraine.

A simple injection once a month or once every three monthsFew side effects, suitable for long-term useEffective for patients who responded poorly to previous treatmentReduces both attack frequency and pain intensity

It achieves a marked reduction in headache compared with conventional preventive treatment, with almost none of the drowsiness, dry mouth, memory disturbance, or swelling seen with older agents.

※ This is general medical information provided for understanding only. Whether and how to treat is determined by a specialist after examination, based on the individual patient's condition.

Advanced Equipment

  • SIEMENS3T AI MRIWe add AI imaging (Deep Resolve) to a proven Siemens 3T MRI to examine neurological conditions faster and more clearly.
  • MRACerebrovascular and carotid MRAIt accurately evaluates the degree of atherosclerosis, stenosis, structural abnormality, and the presence of aneurysm in the vessels of the brain and neck.
  • Carotid USCarotid UltrasoundCarotid wall thickness and plaque are examined to assess stroke risk.
  • NCS / EMGNerve conduction studiesNerves in the arms, legs, and face are safely stimulated electrically and the responses recorded, establishing whether peripheral nerve damage is present and how severe it is.
  • EPEvoked potential testBy safely stimulating the visual and auditory pathways electrically, damage to the cranial nerves can be identified.
  • EEGAI digital EEGBeyond the conventional identification of epileptiform waveforms, quantitative EEG with the latest AI software aids in assessing brain function in headache, anxiety, and depression.
  • VNGVideo nystagmographyBy recording and analyzing involuntary eye movement on video, this test is useful for distinguishing dizziness disorders such as BPPV and Meniere's disease.
  • HRV / SSRAutonomic Function TestEquipment that objectively assesses the balance between the body's sympathetic and parasympathetic nerves.
  • PWV / ABIArterial elasticity testingBy measuring vessel elasticity and the degree of atherosclerosis, it readily assesses the risk of circulatory disturbance and cardiovascular or cerebrovascular disease.
  • Wearable ECG/BPWearable cardiac function testingA micro-sensor continuously analyzes blood pressure and ECG over 24 hours to identify cardiac dysfunction capable of causing a stroke.
  • SNSB / CERADNeuropsychological testingIt distinguishes simple forgetfulness from dementia and objectively evaluates cognitive function including memory.
  • LABBlood and genetic testingWe identify risk factors for cardiovascular and cerebrovascular disease, including dyslipidemia, and look for high-risk dementia genes in advance so that prevention can begin.